The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025. The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025. | | |
|
This Class II recall includes more than 18,000 cannulae used during cardiac surgery. This Class II recall includes more than 18,000 cannulae used during cardiac surgery. | | |
|
"Pulmonary embolism is fundamentally a cardiovascular disease, where restoration of hemodynamic stability, beyond simple clot removal, is the key determinant of patient recovery,” one researcher explained. "Pulmonary embolism is fundamentally a cardiovascular disease, where restoration of hemodynamic stability, beyond simple clot removal, is the key determinant of patient recovery,” one researcher explained. | | |
|
The Alliance for Aging Research wants CMS to go through with policy changes that could make many more patients eligible for TAVR. The agency is currently considering the changes, and a final decision is expected in June. The Alliance for Aging Research wants CMS to go through with policy changes that could make many more patients eligible for TAVR. The agency is currently considering the changes, and a final decision is expected in June. | | |
|
|
The purchase price could end up being closer to $200 million if certain commercial milestones are met. The purchase price could end up being closer to $200 million if certain commercial milestones are met. | | |
|
Ziad Ali, MD, said the new device has completely changed the way he and his colleagues treat patients with calcified coronary artery disease. Ziad Ali, MD, said the new device has completely changed the way he and his colleagues treat patients with calcified coronary artery disease. | | |
|
These three-year data represent a major update to one of the more noteworthy TAVR trials in recent memory. These three-year data represent a major update to one of the more noteworthy TAVR trials in recent memory. | | |
|
|
According to a new survey, both cardiologists and noncardiologists feel good about the specialty's long-term health. According to a new survey, both cardiologists and noncardiologists feel good about the specialty's long-term health. | | |
|
Mina Chung, MD, who just concluded a one-year term as Heart Rhythm Society's president, spoke to Cardiovascular Business about successes from the past year as well as her goals for the future. Mina Chung, MD, who just concluded a one-year term as Heart Rhythm Society's president, spoke to Cardiovascular Business about successes from the past year as well as her goals for the future. | | |
|
The move, once finalized, helps Johnson & Johnson add multiple FDA-approved technologies to its EP portfolio. The move, once finalized, helps Johnson & Johnson add multiple FDA-approved technologies to its EP portfolio. | | |
|
|
Western medicine often functions more like a high-tech patient-processing machine than a high-touch people-healing mission. This can and must change, argue three distinguished healthcare thought leaders. Western medicine often functions more like a high-tech patient-processing machine than a high-touch people-healing mission. This can and must change, argue three distinguished healthcare thought leaders. | | |
|
The state with the worst illicit drug problem is also home to the largest percentage of teenage users. The state with the worst illicit drug problem is also home to the largest percentage of teenage users. | | |
|
